R. Brauner, P. Czernichou, C. Prevot, H.J. Guyda, R . Rappaport. INSERM U30, P a r i s and Mc G i l l U n i v e r s i t y , Nontreal.
I n o r d e r t o d e f i n e c h a r a c t e r i s t i c s and timing of GH d e f i c i e n c y a f t e r c r a n i a l i r r a d i a t i o n a l o n g i t u d i n a l study was performed on 16 c h i l d r e n ( 2 t o 1 5 y r ) a f t e r ) 3000 r a d s f o r medulloblastoma (n=9) o r o t h e r p o s t e r i o r f o s s a tumors ( n = 7 ) . A t o n s e t (TO), a f t e r 1 ( T I ) and 2 y r (T2) GH s e c r e t i o n was a s s e s s e d by 1 ) GH peak response t o AITT, 2 ) s l e e p GH peak, 3 ) plasma SmC/IGF I (RIA) and Sm ( b i o a s s a y ) expressed a s % of normal v a l u e s based on age and p u b e r t a l s t a n d a r d s . A t TO and T1 t h e mean (n=13) GH (AITT) peak values were r e s p e c t i v e l y 21.8 2 12.2 (SD) and 12.2 ? 5.7 ng/ml (~~0 . 0 2 ) .
I n 7 c a s e s f u l l y e v a l u a t e d a t T1 and T2 t h e frequency of GH s e c r e t i o n a b n o r m a l i t i e s were a s shown below (GH, ng/ml) CH AITT peak < 8 GH s l e e p peak < I 0 SnC/IGF I < 5 0 % a t 1 y r 2 3 5 a t 2 y r 5 3 4 A t t i n e T2 3/7 c h i l d r e n had complete GH d e f i c i e n c y . The mean SnC/IGF I values a t T1 and T2 were r e s p e c t i v e l y 0.54 i 0.26 and 0.57 $ 0.35 %. Sm by bioassay d i d not show any c l e a r c o r r e l a t i o n with RIA. From TO t o T2 t h e mean h e i g h t l o s s was 1.21 ' 0 . 4 SD ( -0.8 t o -1 . 8 SD) a t T2 i n t h i s group. In conclusion, t h i s study demonstrated t h e e a r l y occurence of various GH s e c r e t o r y d i s t u r b a n c e s and growth r e t a r d a t i o n . I t should provide f u r t h e r information on t h e mechanism of radiation induced GH d e f i c i e n c y and help t o d e f i n e t h e r a p e u t i c s t r a t e g i e s (supported by INSERX g r a n t , 1 ! 8 2 ) .
--GROWTH HOIL' IONE DEFICIENCY: INTERLEUKIN 2 (IL2) AND 5 8 IXMUNE FUNCTION. Robert Rapaport, James Oleske, Selva Schenkman, Jeanne C h u r c h i l l , Charles Kirkpatr i c k . UMDNJ-New J e r s e y Xedical School, Newark, N J , Dept. of Pep d i a t r i c s and National Asthma C e n t e r , Denver, CO IL2 production i n response t o phytohemagglutinin (PHA) was measured i n 5 p a t i e n t s w i t h growth hormone d e f i c i e n c y (GHD)(ages 7.8-14.5). I n 3 p a t i e n t s IL2 was determined b e f o r e and 24 h r s a f t e r t h e f i r s t dose (2 u n i t s ) of human growth hormone (HGH) adm i n i s t r a t i o n . I n 2 p a t i e n t s IL2 was measured a f t e r 1 and 16 months of HGH t r e a t m e n t . At no time could IL2 production be ide* t i f i e d i n t h e s e p a t i e n t s . I n c o n t r a s t 1 p a t i e n t (age 14) w i t h s h o r t s t a t u r e and normal G H responses t o s t a n d a r d s t i m u l a t o r y t e s t s on treatment w i t h exogenous HGH f o r 6 months d i d produce IL2 normally.
We have p r e v i o u s l y p r e s e n t e d d a t a (Society P e d i a t r i c Research 1984) demonstrating t h a t continuous t r e a t m e n t with HGH f o r l y e a r r e s u l t e d i n t r a n s i e n t d e c r e a s e i n % B c e l l s , T h e l p e r / s u p p r e s s o r (T HIS) r a t i o and PHA responsiveness i n 8 GHD p a t i e n t s . \ h e n t r e a t m e n t was i n t e r r u p t e d f o r 1-2 month i n t e r v a l s , r e s t a r t i n g HGH r e s u l t e d i n a f a l l i n % B c e l l s i n 517 p a t i e n t s , mean 17.6% (range 12-20) t o 7.8% (range 6-11) and a f a l l i n T HIS r a t i o i n 417 p a t i e n t s , mean 1.83 (range 1.5-2.0) t o 1.20 (range 1.0-1.4) a f t e r 1-2 months of t r e a t m e n t . Serum immunoglobulins and polymorphonuclear leukocyte f u n c t i o n was n o t a f f e c t e d by 9GH t r e a tment f o r up t o 24 months i n any p a t i e n t . I n conclusion I n t e r l e u k i n 2 production, u n l i k e o t h e r immune parameters, i s impaired i n growth hormone d e f i c i e n t p a t i e n t s and i s u n a f f e c t e d by human growth hormone t r e a t m e n t .
PRECOCIOUS PUBERTY AND GROI\TH HORYONE DEFICIENCY

(GHD) FOLLOWING CRANIAL IRRADIATION (cI). ~obert
Rapaport, Selva Schenkman, Jeanne C h u r c h i l l , Beverly Ryan, Maria I. New. UZIDNJ-New J e r s e y Medical School, Newark, N J and Cornell Xedical College, New York, W , Depts. of P e d i a t r i c s GHD and p u b e r t a l d e l a y a r e known t o occur following C I i n c h i l d r e n . We r e p o r t 3 g i r l s who developed precocious puberty and GHD a f t e r r e c e i v i n g C I . The c l i n i c a l d a t a a r e shown below.
P t C 1
Age*:onset puberty -c u r r e n t -6.5 6 7.4 sarcoma(ear) '2500 ear *Age i n y r s ; d o s e i n r a d s ; +pub h a i r P a t i e n t s 81 and 82 grew a t annual growth r a t e s of 6.5 and 6.3 cm b e f o r e menarche. GHD was diagnosed a f t e r menarche i n b o t h . P t /I1 r e c e i v e d human growth hormone between t h e ages of 9.5 and 11.8. T h e i r p r e d i c t e d a d u l t h e i g h t s (PAH) (method of Greulich and Pyle) were 141 and 142 cm. P t 83 evaluated a t t h e age of 6 . 5 was growing a t 6.7 cmlyr. Her serum e s t r a d i o l was 1 . 0 n g / d l and h e r peak serum LH and FSH following LFaH a d m i n i s t r a t i o n (100 p g ) were 11.9 and 1 7 . 1 mIU/ml. Her PAH was 149 cm. No demonstrable c r a n i a l , a d r e n a l o r o v a r i a n cause f o r precocious puberty was found i n any of t h e p a t i e n t s .
We r e p o r t h e r e evidence t h a t C I can r e s u l t i n both hypothalarnic p i t u i t a r y hypofunction and hyperfunction i n t h e same i n d i v idual. Finding "normal" growth r a t e s i n such p a t i e n t s does n o t P r o l a c t i n ( P r l ) Secreti.on i n Lone-term Survivors I,£ Acute Lymphoblastic Leukemia (ALL).
6o Charles A. S k l a r , S a u l A. Rothenberg, Theodore W. 
The therapy employed f o r t h e treatment of childhood ALL i s known t o cause d i s t u r b a n c e s i n t h e neuroendocrine c o n t r o l of growth hormone (GH) s e c r e t i o n . Recent d a t a suggest t h a t t h i s i s due p r i m a r i l y t o hypothalamic damage. Since P r l l e v e l s a r e f r equently e l e v a t e d and d i u r n a l v a r i a t i o n i s l o s t when hypothalarnic
damage i s p r e s e n t , we a s s e s s e d P r l s e c r e t i o n i n a group of longterm s u r v i v o r s of ALL. We s t u d i e d 5 males between t h e ages of 11 8/12 -20 5/12 y r s . The p a t i e n t s were e u t h y r o i d and had been o f f treatment f o r 2-10 y r s . 4 of 5 had received c r a n i a l r a d i at i o n (2400 r a d s ) . 2 of 4 i r r a d i a t e d p a t i e n t s had demonstrated blunted peak GH l e v e l s (<7 nglml) during s l e e p . P r l l e v e l s were determined i n PX p r i o r t o s l e e p (q 30 min) and q 20 minutes during s l e e p .
The awake P M P r l c o n c e n t r a t i o n s i n p a t i e n t s (8.7 i-1.0 n g / n l ) were not d i f f e r e n t from c o n t r o l s (5.6f 0.8 ng/ml). T h e p a t i e n t s ' mean P r l l e v e l s during s l e e p (13.9 i 0.7 ng/ml) and mean P r l output (476 i 98 a r e a u n i t s ) were n o t s i g n i f i c a n t l y d i f f e r e n t From those of t h e c o n t r o l s (9.0 ? 0.4 ng/ml and 333 i 40 a r e a u n i t s ) . A l l p a t i e n t s showed normal augmentation of P r l durinz; s l e e p . These r e s u l t s suggest t h a t t h e neuroendocrinc mechanisms c o n t r o l l i n g P r l s e c r e t i o n a r e l e s s s e n s i t i v e t o t h e t o x i c e f f e c t s of ALL therapy than t h o s e c o n t r o l l i n g GH s e c r e t i o n . c e n t r a t i o n s o f PTU w e r e m e a s u r e d i n n e e d l e b i o p s y specimens a n d w e r e 2 . 0 6 -4 . 3 1 p g / g , 4 . 5 6 -1 7 . 8 p g / g a n d 1 . 0 9 -4 . 4 8 p g / g a t 2 , 1 2 a n d 24 h r s a f t e r 2 0 0 mg/mLof PTU r e s p e c t i v e l y . I n t r a t h y r o i d a l M M I w a s m e a su r e d i n surgically o b t a l n e d s p e c i m e n s a n d w a s 1.1-L.3 p g / g a n d 0 . 7 8 -1 . 4 0 p g / g a t 5 a n d 1 8 h r s a f t e r 1 0 --20 mg/m20f M M I r e s p e c t i v e l y . T h e s e v a l u e s f a r e x c e e d e d t h e p l a s m a v a l u e s a t t h e r e s p e c t i v e t i m e s e x c e p t f o r 2 h r s a f t e r PTU. Our r e s u l t s indicate: 1) e l l m i n a t l o n o f PTU a n d M M I f r o m t h e t h y r o i d g l a n d i s much s l o w e r t h a n f r o m p l a s m a , a n d 2 ) a s l n g l e d a l l y d o s e o f PTU o r M M I i s a d e q u a t e f o r t h e t r e a t m e n t o f G r a v e s d i s e a s e . Brahm Shapiro, and James C. Sisson, University of Michigan Medical School, Depts. of Pediatrics and Int. Med., Ann Arbor, MI USA Two boys, 7 and 9 yrs, and a girl, 11 yrs, presented with goiters and h perthyroxinemia. The boys were treated with PTU/thyroidectomy or I1& for suspected thyrotoxicosis, but had poorly suppressible serum TSH post Rx. The girl had increasing goiter size on PTU 100 mg q 8 1 1 X 1 mo. These findings led to re-evaluation of thyroid hormone dynamics in these patients and their families. The diagnosis of partial peripheral and pituitary resistance to thyroid hormone was made in the 3 index cases and 12 additional family members, ages 3-38 yrs, compatible with an autosomal dominant inheritance. A11 had elevated serum T4 RIA (13.9-25.8~g/dl), Tg RIA (205-396 ngldl), and non-suppressed serum TSH (1.5-158 pU/ml). T3 resin uptakes were N-slf.
Reverse T3, f1.ee Tq and 24h 1131 uptakes were f in 616. Goiters were present in 101'11 (4 were post thyroid ablation). TRH (200 ug iv) given to 5 pts (from 3 families) showed exaggerated TSH responses (A uU/ml = 26, 3 1 , 32, 34, 268) . After incremental doses of L-thyroxine up to 0.3 m d d , goiter size decreased, and TSH response to TRH was now normal (A 17,19 pU/ml) in 2 pts with intact thyroids and still exaggerated (A 96 pU/ml) in the pt with 1131 Rx. Misdiagnosis in 6/15 members of 3 families has led to significant morbidity (hypothyroidism, delayed growth, Rx risk). Appropriate management for this condition should include Lthyroxine in order to decrease goiter size and normalize TSH responses to TRH. A non-suppressed TSH in a patient with suspected thyrotoxicosis should lead to suspicion of this disorder. o b v i a t e the need f o r e v a l u a t i n g t h e i r growth hormone dynamics.
